Larvol Delta - Brenig-Therapeutics-Unveils-Superior-Safety-Prole-of-LRRK2-Inhibitor-BT0267-with-Exceptional-CSFPlasma-Ratio-at-Future-of-Parkinson39s-Disease-Conference

BT-0267 - Brenig Therap

https://www.prnewswire.com/news-releases/brenig-therapeutics-unveils-superior-safety-profile-of-lrrk2-inhibitor-bt-0267-with-exceptional-csfplasma-ratio-at-future-of-parkinsons-disease-conference-302005055.html

Dec 4, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev